Properties of procoagulant platelets: Defining and characterizing the subpopulation binding a functional prothrombinase

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 12, 2010, Pages 2400-2407

  Fager, Ammon M ^a   Wood, Jeremy P ^a   Bouchard, Beth A ^a   Feng, Ping ^a   Tracy, Paula B ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

adhesion molecules; coagulation; factor V; platelets; thrombin

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5A; PADGEM PROTEIN; THROMBIN;

ARTICLE; CELL SUBPOPULATION; CONTROLLED STUDY; ENZYME RELEASE; HEMOSTASIS; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR DENSITY; THROMBOCYTE; THROMBOCYTE ACTIVATION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD COAGULATION; BLOOD PLATELETS; FACTOR VA; FACTOR XA; FLOW CYTOMETRY; HUMANS; INTEGRIN ALPHA2; INTEGRIN BETA3; MEMBRANE GLYCOPROTEINS; MICROSCOPY, FLUORESCENCE; MIDDLE AGED; P-SELECTIN; PHENOTYPE; PLATELET ACTIVATION; PLATELET ADHESIVENESS; PROTEIN BINDING; THROMBIN;

EID: 78650420325     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.110.216531     Document Type: Article

References (32)

1. Kalafatis M, Egan JO, Van 't Veer C, Cawthern KM, Mann KG. The regulation of clotting factors. Crit Rev Eukaryot Gene Expr. 1997;7: 241-280.
2. Strukova SM. Thrombin as a regulator of inflammation and reparative processes in tissues. Biochemistry (Mosc). 2001;66:8-18.
3. Martorell L, Martinez-Gonzalez J, Rodriguez C, Gentile M, Calvayrac O, Badimon L. Thrombin and protease-activated receptors (PARs) in athero-thrombosis. Thromb Haemost. 2008;99:305-315.
4. Osterud B, Rapaport SI, Lavine KK. Factor V activity of platelets: evidence for an activated factor V molecule and for a platelet activator. Blood. 1977;49:819-834.
5. Bouchard BA, Williams JL, Meisler NT, Long MW, Tracy PB. Endo-cytosis of plasma-derived factor V by megakaryocytes occurs via a clathrin-dependent, specific membrane binding event. J Thromb Haemost. 2005;3:541-551.
6. Gould WR, Simioni P, Silveira JR, Tormene D, Kalafatis M, Tracy PB. Megakaryocytes endocytose and subsequently modify human factor V in vivo to form the entire pool of a unique platelet-derived cofactor. J Thromb Haemost. 2005;3:450-456.
7. Gould WR, Silveira JR, Tracy PB. Unique in vivo modifications of coagulation factor V produce a physically and functionally distinct platelet-derived cofactor: characterization of purified platelet-derived factor V/Va. J Biol Chem. 2004;279:2383-2393.
8. Conlon SJ, Camire RM, Kalafatis M, Tracy PB. Cleavage of platelet-derived factor Va by plasmin results in increased and sustained cofactor activity on the thrombin-activated platelet surface. Thromb Haemost. 1997;77(suppl):616. Abstract PS-2507.
9. Camire RM, Kalafatis M, Simioni P, Girolami A, Tracy PB. Platelet-derived factor Va/Va Leiden cofactor activities are sustained on the surface of activated platelets despite the presence of activated protein C. Blood. 1998;91:2818-2829.
10. Bouchard BA, Catcher CS, Thrash BR, Adida C, Tracy PB. Effector cell protease receptor-1, a platelet activation-dependent membrane protein, regulates prothrombinase-catalyzed thrombin generation. J Biol Chem. 1997;272:9244-9251.
11. Karpatkin S. Heterogeneity of human platelets: II: functional evidence suggestive of young and old platelets. J Clin Invest. 1969;48:1083-1087.
12. Karpatkin S. Heterogeneity of human platelets: I: metabolic and kinetic evidence suggestive of young and old platelets. J Clin Invest. 1969;48: 1073-1082.
13. Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL. Surface expression and functional characterization of a-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin. Blood. 2000;95:1694-1702.
14. Batar P, Dale GL. Simultaneous engagement of thrombin and Fc y RIIA receptors results in platelets expressing high levels of procoagulant proteins. J Lab Clin Med. 2001;138:393-402.
15. Dale GL, Friese P, Batar P, Hamilton SF, Reed GL, Jackson KW, Clemetson KJ, Alberio L. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature. 2002;415:175-179.
16. Kempton CL, Hoffman M, Roberts HR, Monroe DM. Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations. Arterioscler Thromb Vasc Biol. 2005;25:861-866.
17. Panteleev MA, Ananyeva NM, Greco NJ, Ataullakhanov FI, Saenko EL. Two subpopulations of thrombin-activated platelets differ in their binding of the components of the intrinsic factor X-activating complex. J Thromb Haemost. 2005;3:2545-2553.
18. London FS, Marcinkiewicz M, Walsh PN. A subpopulation of platelets responds to thrombin- or SFLLRN-stimulation with binding sites for factor IXa. J Biol Chem. 2004;279:19854-19859.
19. Munnix IC, Kuijpers MJ, Auger J, Thomassen CM, Panizzi P, Van Zandvoort MA, Rosing J, Bock PE, Watson SP, Heemskerk JW. Segregation of platelet aggregatory and procoagulant microdomains in thrombus formation: regulation by transient integrin activation. Arterioscler Thromb Vasc Biol. 2007;27:2484-2490.
20. Tracy PB, Nesheim ME, Mann KG. Platelet factor Xa receptor. Methods Enzymol. 1992;215:329-360.
21. Hayes KL, Leong L, Henriksen RA, Bouchard BA, Ouellette L, Church WR, Tracy PB. a-Thrombin-induced human platelet activation results solely from formation of a specific enzyme-substrate complex. J Biol Chem. 1994;269:28606-28612.
22. Thattaliyath B, Cykowski M, Jagadeeswaran P. Young thrombocytes initiate the formation of arterial thrombi in zebrafish. Blood. 2005;106: 118-124.
23. Wood JP, Fager AM, Silveira JR, Tracy PB. Platelet-derived factor Va expressed on the surface of the activated platelet is GPI-anchored. Blood. 2008;112:219a.
24. Tracy PB, Eide LL, Mann KG. Human prothrombinase complex assembly and function on isolated peripheral blood cell populations. J Biol Chem. 1985;260:2119-2124.
25. Nesheim ME, Furmaniak-Kazmierczak E, Henin C, Cote G. On the existence of platelet receptors for factor V(a) and factor VIII(a). Thromb Haemost. 1993;70:80-86.
26. van Gils JM, Zwaginga JJ, Hordijk PL. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leukoc Biol. 2009;85:195-204.
27. Szasz R, Dale GL. Thrombospondin and fibrinogen bind serotonin- derivatized proteins on COAT-platelets. Blood. 2002;100:2827-2831.
28. Francis RT, McDonagh J, Mann KG. Factor V is a substrate for the transamidase factor XIIIa. J Biol Chem. 1986;261:9787-9792.
29. Jobe SM, Leo L, Eastvold JS, Dickneite G, Ratliff TL, Lentz SR, Di Paola J. Role of FcRy and factor XIIIA in coated platelet formation. Blood. 2005;106:4146-4151.
30. Dale GL. Coated-platelets: an emerging component of the procoagulant response. J Thromb Haemost. 2005;3:2185-2192.
31. Italiano JE Jr, Richardson JL, Patel-Hett S, Battinelli E, Zaslavsky A, Short S, Ryeom S, Folkman J, Klement GL. Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet a granules and differentially released. Blood. 2008;111: 1227-1233.
32. Sehgal S, Storrie B. Evidence that differential packaging of the major platelet granule proteins von Willebrand factor and fibrinogen can support their differential release. J Thromb Haemost. 2007;5:2009-2016.